Page last updated: 2024-09-04

fusidic acid and Diathesis

fusidic acid has been researched along with Diathesis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burbujo, J; Calderón-Komaromy, A; Córdoba, S; de Pablo, NP; Freites-Martínez, A; Martinez-Sánchez, D	1
Belloni Fortina, A; Neri, L	1
Kamel, AG; Lim, VK; Norazah, A; Rohani, MY	1

Reviews

1 review(s) available for fusidic acid and Diathesis

Article	Year
Antibiotic therapy in the management of atopic dermatitis. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2015, Volume: 150, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Antigens, Bacterial; Child; Dermatitis, Atopic; Disease Susceptibility; Disinfectants; Drug Resistance, Microbial; Drug Therapy, Combination; Fusidic Acid; Humans; Skin; Skin Diseases, Bacterial; Sodium Hypochlorite; Staphylococcal Skin Infections; Staphylococcus aureus; Superantigens; Superinfection	2015

Article

Year

Antibiotic therapy in the management of atopic dermatitis.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2015, Volume: 150, Issue:3

Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Antigens, Bacterial; Child; Dermatitis, Atopic; Disease Susceptibility; Disinfectants; Drug Resistance, Microbial; Drug Therapy, Combination; Fusidic Acid; Humans; Skin; Skin Diseases, Bacterial; Sodium Hypochlorite; Staphylococcal Skin Infections; Staphylococcus aureus; Superantigens; Superinfection

2015

Other Studies

2 other study(ies) available for fusidic acid and Diathesis

Article	Year
[Exudative onycholysis and acute bacterial paronychia related to BIBF-1120 and paclitaxel: response to topical therapy]. Investigacion clinica, 2014, Volume: 55, Issue:1 Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Susceptibility; Female; Fusidic Acid; Hand; Humans; Indoles; Methylprednisolone; Middle Aged; Onycholysis; Paclitaxel; Paronychia; Staphylococcal Skin Infections	2014
In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals. The Medical journal of Malaysia, 2005, Volume: 60, Issue:4 Topics: Anti-Bacterial Agents; Aza Compounds; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fusidic Acid; Humans; In Vitro Techniques; Levofloxacin; Malaysia; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Rifampin; Staphylococcus aureus; Virginiamycin	2005

Article

Year

[Exudative onycholysis and acute bacterial paronychia related to BIBF-1120 and paclitaxel: response to topical therapy].

Investigacion clinica, 2014, Volume: 55, Issue:1

Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Susceptibility; Female; Fusidic Acid; Hand; Humans; Indoles; Methylprednisolone; Middle Aged; Onycholysis; Paclitaxel; Paronychia; Staphylococcal Skin Infections

2014

In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.

The Medical journal of Malaysia, 2005, Volume: 60, Issue:4

Topics: Anti-Bacterial Agents; Aza Compounds; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fusidic Acid; Humans; In Vitro Techniques; Levofloxacin; Malaysia; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Rifampin; Staphylococcus aureus; Virginiamycin

2005